Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Q Lacy

Showing results (61-70 of 142) with videos related to

Pageof 15
Sort By:
Bone Marrow Transplantation|July 22, 1999
Autologous stem cell transplantation for relapsed and primary refractory myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Bone Marrow Transplantation|August 23, 2016
The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agentsR Chakraborty, E Muchtar, S Kumar, et al.
Bone Marrow Transplantation|July 22, 1999
Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Leukemia|June 22, 2007
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myelomaS Kumar, A Dispenzieri, M Q Lacy, et al.
Leukemia|January 30, 2004
Effect of thalidomide therapy on bone marrow angiogenesis in multiple myelomaS Kumar, T E Witzig, A Dispenzieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Prognostic value of bone marrow angiogenesis in multiple myelomaS V Rajkumar, T Leong, P C Roche, et al.
Blood|April 6, 2001
A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and deathD P Steensma, M A Gertz, P R Greipp, et al.
Bone Marrow Transplantation|November 14, 2017
Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantationR Chakraborty, E Muchtar, S K Kumar, et al.
Bone Marrow Transplantation|October 26, 2010
SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalizationM A Gertz, D A Gastineau, M Q Lacy, et al.
Bone Marrow Transplantation|June 1, 2004
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapyS Kumar, M A Gertz, A Dispenzieri, et al.
Pageof 15

Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Bone Marrow Transplantation|July 22, 1999
Autologous stem cell transplantation for relapsed and primary refractory myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Bone Marrow Transplantation|August 23, 2016
The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agentsR Chakraborty, E Muchtar, S Kumar, et al.
Bone Marrow Transplantation|July 22, 1999
Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Leukemia|June 22, 2007
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myelomaS Kumar, A Dispenzieri, M Q Lacy, et al.
Leukemia|January 30, 2004
Effect of thalidomide therapy on bone marrow angiogenesis in multiple myelomaS Kumar, T E Witzig, A Dispenzieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Prognostic value of bone marrow angiogenesis in multiple myelomaS V Rajkumar, T Leong, P C Roche, et al.
Blood|April 6, 2001
A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and deathD P Steensma, M A Gertz, P R Greipp, et al.
Bone Marrow Transplantation|November 14, 2017
Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantationR Chakraborty, E Muchtar, S K Kumar, et al.
Bone Marrow Transplantation|October 26, 2010
SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalizationM A Gertz, D A Gastineau, M Q Lacy, et al.
Bone Marrow Transplantation|June 1, 2004
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapyS Kumar, M A Gertz, A Dispenzieri, et al.
Pageof 15